BioXcel Therapeutics
BTAI
#11149
Rank
โ‚ฌ2.02 M
Marketcap
0,06459ย โ‚ฌ
Share price
0.00%
Change (1 day)
-97.26%
Change (1 year)

EPS for BioXcel Therapeutics (BTAI)

EPS in 2026 (TTM): -5,79ย โ‚ฌ

According to BioXcel Therapeutics's latest financial reports the company's current EPS (TTM) is -5,83ย โ‚ฌ. In 2024 the company made an earnings per share (EPS) of -22,65ย โ‚ฌ an increase over its 2023 EPS that were of -86,00ย โ‚ฌ.

EPS history for BioXcel Therapeutics from 2020 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-5,79ย โ‚ฌ
2024-22,65ย โ‚ฌ-73.67%
2023-86,00ย โ‚ฌ4.06%
2022-82,65ย โ‚ฌ44.85%
2021-57,05ย โ‚ฌ7.65%
2020-53,00ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
-1,26ย โ‚ฌ-78.41%๐Ÿ‡บ๐Ÿ‡ธ USA